Healthcare

Americans have different ideas about how healthcare should work.

But most agree the system should provide

high-quality care without financial devastation.

America spends more on healthcare than any other country in the world.

Yet millions of Americans still struggle to afford care.

Why?

Because much of the system focuses on treating symptoms instead of solving diseases.

Cancer.
Parkinson’s disease.
Alzheimer’s.
ALS.
Heart disease.

These illnesses take hundreds of thousands of lives every year.

But they rarely trigger the same urgent global response we see during sudden outbreaks.

When COVID-19 appeared, governments, universities, and pharmaceutical companies worked together at unprecedented speed.

Vaccines were developed in less than a year.

When Ebola outbreaks occur, the world mobilizes quickly to develop treatments.

So the question becomes:

Why don’t we approach slow and deadly diseases with the same urgency?

Cancer alone kills about 600,000 Americans and nearly 10 million people worldwide every year.

Yet research is often fragmented between universities, private companies, and government agencies competing for breakthroughs.

What if they worked together?

Research institutions could coordinate their work and share knowledge to accelerate cures.

Treatments help people live longer.

Cures eliminate the disease entirely.

Healthcare challenges also appear in everyday situations.

Many Americans have experienced a system where prices seem impossible to understand.

A doctor might charge $75 directly.

But the same visit could be billed to insurance for $300.

Hospitals sometimes charge extremely high prices for simple items like aspirin or bandages.

Not because they cost that much.

But because of how the billing system works.

In the end, those costs don’t disappear.

They simply show up on the patient’s bill.

Other countries approach everyday treatment differently.

In places like the Netherlands and across parts of Europe, pharmacists often guide patients to a small set of medicines that match their symptoms.

In the United States, patients often face long rows of nearly identical brand-name products and must figure out which one to choose on their own.

Sometimes a single treatment can replace entire shelves of brand-name options.

America has some of the best doctors and medical researchers in the world.

But the system surrounding them is often confusing, expensive, and slow to change.

The question is not whether America can lead in healthcare.

The question is whether we choose to build a system focused on cures, transparency, and common sense.

This just makes sense.

Why haven't we done this already?

Someone shared this with you.
Pass it on.

One voice at a time—until it's not quiet anymore.